oncolytic

简明释义

英[ˌɒŋ.kəˈlɪ.tɪk]美[ˌɑŋ.kəˈlɪ.tɪk]

adj. 溶瘤细胞的

英英释义

单词用法

同义词

反义词

例句

1.Information available at present suggests that Oncovin may be useful either alone or in conjunction with other oncolytic drugs for the treatment of acute leukaemias ……

据现有资料表明，硫酸长春新碱可单独使用，亦可与其他溶瘤细胞药物合用，以治疗急性白血病……

2.Information available at present suggests that Oncovin may be useful either alone or in conjunction with other oncolytic drugs for the treatment of acute leukaemias ……

据现有资料表明，硫酸长春新碱可单独使用，亦可与其他溶瘤细胞药物合用，以治疗急性白血病……

3.This new oncolytic adenovirus mutant has good clinical prospect in gene curing so to used in curing many kinds of human tumors.

该新型溶瘤腺病毒突变体在基因治疗中具有良好的临床应用前景，可用于多种人体肿瘤的治疗。

4.The study was to observe the induction of abscopal effect by the combination of H101 oncolytic virotherapy with local heating.

本研究探索溶瘤腺病毒h 101局部注射结合局部加热治疗诱发远端抗瘤效应的可行性。

5.In this review, tumor targeting, killing efficiency, safety and the evaluation of oncolytic viruses therapy are discussed.

文章简要综述了溶瘤病毒肿瘤治疗的靶向性、杀伤性、安全性和疗效监测。

6.Objective:To evaluate the selectively oncolytic effect of conditionally replicating adenovirus CNHK500 in breast cancer.

目的：观察选择性增殖腺病毒CNHK500对乳腺癌的特异性杀伤作用。

7.In comparison, oncolytic viruses can replicate and spread and theoretically can efficiently reach more tumor cells.

相比之下，溶瘤病毒就可以复制传播，理论上可以到达更多的肿瘤细胞。

8.The field of oncolytic viruses is a growing area in identifying new therapies for treating cancer.

溶瘤病毒领域是一个正在成长的治疗癌症的领域。

9.Conclusion: Different tumor cell lines showed different VSV oncolytic sensitivities;

结论：不同的肿瘤细胞对VSV病毒溶瘤的敏感性不同；

10.Researchers are developing new oncolytic 肿瘤溶解性 viruses to target cancer cells more effectively.

研究人员正在开发新的肿瘤溶解性病毒，以更有效地针对癌细胞。

11.The clinical trial focused on the use of oncolytic 肿瘤溶解性 therapies for patients with advanced melanoma.

临床试验专注于为晚期黑色素瘤患者使用肿瘤溶解性疗法。

12.One promising approach in cancer treatment is the application of oncolytic 肿瘤溶解性 viruses that selectively kill tumor cells.

癌症治疗中一种有前景的方法是应用选择性杀死肿瘤细胞的肿瘤溶解性病毒。

13.Scientists are investigating how oncolytic 肿瘤溶解性 agents can enhance the immune response against tumors.

科学家们正在研究肿瘤溶解性药物如何增强对肿瘤的免疫反应。

14.The potential of oncolytic 肿瘤溶解性 virotherapy has opened new avenues for cancer treatment.

肿瘤溶解性病毒治疗的潜力为癌症治疗开辟了新途径。

作文

The field of medicine is constantly evolving, and one of the most promising areas of research today is in the realm of cancer treatment. Among the various approaches being explored, oncolytic therapies have emerged as a particularly exciting avenue. Oncolytic refers to a type of therapy that utilizes viruses to selectively infect and destroy cancer cells while sparing normal cells. This innovative approach offers new hope for patients who have exhausted other treatment options. Traditionally, cancer treatments such as chemotherapy and radiation therapy have been the cornerstone of oncological care. However, these methods often come with significant side effects due to their impact on healthy cells. In contrast, oncolytic therapies aim to exploit the unique vulnerabilities of cancer cells. By using genetically modified viruses, researchers can create agents that specifically target and kill tumor cells. This selective action minimizes damage to surrounding healthy tissues and can lead to improved patient outcomes. One of the most compelling aspects of oncolytic therapies is their dual action. Not only do these viruses directly kill cancer cells, but they also stimulate the immune system to recognize and attack tumors. This immune response can lead to a systemic effect, where the body’s defenses are enhanced to fight off cancer not just at the site of infection but throughout the entire body. This characteristic makes oncolytic therapies a potential game-changer in the field of oncology. Numerous clinical trials are currently underway to evaluate the effectiveness of oncolytic viruses in treating various types of cancer, including melanoma, glioblastoma, and pancreatic cancer. Preliminary results have been promising, showing not only tumor reduction but also prolonged survival rates in some patients. These findings suggest that oncolytic therapies could be an integral part of a multi-faceted approach to cancer treatment, potentially used in combination with existing therapies to enhance their efficacy. However, despite the excitement surrounding oncolytic therapies, there are challenges that researchers must overcome. One major hurdle is the immune response to the viruses themselves. While the goal is to harness the immune system to fight cancer, the body can also recognize the introduced viruses as foreign invaders and mount a defense against them. This immune response can limit the effectiveness of the therapy. Ongoing research is focused on modifying these viruses to evade immune detection while still retaining their ability to target cancer cells. In addition, regulatory approval for oncolytic therapies can be a lengthy and complex process. Ensuring the safety and efficacy of these treatments requires extensive testing and validation. As more data becomes available from clinical trials, it is hoped that regulatory bodies will recognize the potential benefits of oncolytic therapies and expedite their approval for use in clinical settings. In conclusion, oncolytic therapies represent a groundbreaking approach in the fight against cancer. By utilizing viruses to selectively target and destroy cancer cells, these treatments offer a new dimension to oncological care. As research continues to advance, it is imperative to remain optimistic about the future of oncolytic therapies and their potential to transform cancer treatment, ultimately improving the quality of life for countless patients worldwide.

医学领域不断发展，今天最有前景的研究领域之一是癌症治疗。在探索的各种方法中，oncolytic（溶瘤）疗法作为一种特别令人兴奋的途径浮出水面。Oncolytic指的是一种利用病毒选择性地感染和摧毁癌细胞，同时保护正常细胞的治疗方法。这种创新的方法为那些已经耗尽其他治疗选择的患者带来了新的希望。 传统上，化疗和放疗等癌症治疗一直是肿瘤学护理的基石。然而，这些方法通常由于对健康细胞的影响而伴随显著的副作用。与此相反，oncolytic疗法旨在利用癌细胞的独特脆弱性。通过使用基因修饰的病毒，研究人员可以创建专门针对并杀死肿瘤细胞的药物。这种选择性作用最小化了对周围健康组织的损害，并可能导致患者结果的改善。 Oncolytic疗法最引人注目的方面之一是其双重作用。这些病毒不仅直接杀死癌细胞，还刺激免疫系统识别并攻击肿瘤。这种免疫反应可以导致全身效应，使身体的防御机制增强，不仅在感染部位对抗癌症，而且在整个身体内。这一特征使得oncolytic疗法在肿瘤学领域成为一个潜在的变革者。 目前，许多临床试验正在进行中，以评估oncolytic病毒在治疗各种类型癌症（包括黑色素瘤、胶质母细胞瘤和胰腺癌）中的有效性。初步结果令人鼓舞，显示出不仅肿瘤缩小，而且一些患者的生存率延长。这些发现表明，oncolytic疗法可能成为癌症治疗多方面方法的重要组成部分，可能与现有疗法结合使用以增强其疗效。 然而，尽管对oncolytic疗法的兴奋，但研究人员必须克服挑战。一个主要障碍是对病毒本身的免疫反应。虽然目标是利用免疫系统对抗癌症，但身体也可以将引入的病毒视为外来入侵者，并对其发起防御。这种免疫反应可能限制治疗的有效性。正在进行的研究集中在修改这些病毒，以避开免疫检测，同时仍保留其靶向癌细胞的能力。 此外，oncolytic疗法的监管批准可能是一个漫长而复杂的过程。确保这些治疗的安全性和有效性需要广泛的测试和验证。随着来自临床试验的数据越来越多，希望监管机构能够认识到oncolytic疗法的潜在好处，加快其在临床环境中的批准。 总之，oncolytic疗法代表了对抗癌症的一种突破性方法。通过利用病毒选择性地靶向和摧毁癌细胞，这些治疗为肿瘤学护理提供了新的维度。随着研究的持续推进，保持对oncolytic疗法未来的乐观态度至关重要，它们具有转变癌症治疗的潜力，最终改善无数患者的生活质量。